Insomnia can be treated non-pharmacologically, by providing guidance as to what good sleeping hygiene principals include, and pharmacologically with the use of OTC products, benzodiazepines, non-benzodiazepines, barbiturates, sedating antidepressants (where there is an underlying depression component), and chloral hydrate.
Worldwide, more than 50 million people have epilepsy, making it one of the most common neurological diseases globally. Nearly 80% of people with epilepsy live in low- and middle-income countries. Despite the fact that epilepsy is a manageable disease, many people living in these countries face stigmatisation and discrimination due to cultural beliefs.
The pharmacist plays a very important role in the diagnosis and referral of patients presenting with headaches, dispensing of medications, and counselling of patients.
Multiple sclerosis (MS) affects about three in every 100 000 people in SA. The good news is that Aubagio (teriflumonide), an affordable, novel, immunomodulatory, disease-modifying oral drug with anti-inflammatory properties, is now available in the country.